Share
477 Posts.
lightbulb Created with Sketch. 27
clock Created with Sketch.
17/04/21
14:49
Share
Originally posted by UniTrader:
↑
Well on what little I know (really based on when ASX listed and G13 and others on HC) it has some revenue that has grown (how much?). It's product is good and not expensive for those who need life monitoring. It exists in both consumer and commercial markets where competition is coming quick (though the product range may not be up to GMVD spec). I feel the new GMVD needs to acknowledge that it cannot be a one man band. The Australian sh may be on bread and water for refusing the Dr his shares but the Americans have spanked him in getting the current proposed listing. How else to explain the complete dud of the first listing last October. Given Dr Yacov was driving the listing, I am hoping the Dr's one-eye view of himself has been knocked down a peg (or two) and I would sincerely hope he allows a more consensus operation. I would even go so far and say that he should not have an executive role. Looking forward: Like G13, getting the fact from fiction may be decisive. But the company needs to be very weary of doing the ASX stuff on the Nasdaq and as I said a more consensus way forward helps.
Expand
I do hope the Dr browses this forum one of these days. Most still invested have supported GMV since being listed on ASX.A better PR would have definitely gone a long way.